Introduction to Biologic and Biosimilar Product Development and Analysis
The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Elektronický zdroj E-kniha |
| Jazyk: | angličtina |
| Vydáno: |
Cham :
Springer International Publishing,
2018.
|
| Vydání: | 1st ed. 2018. |
| Edice: | AAPS Introductions in the Pharmaceutical Sciences,
|
| Témata: | |
| ISBN: | 9783319984285 |
| ISSN: | 2522-834X |
| On-line přístup: |
|
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 003 | SK-BrCVT | ||
| 005 | 20220618100954.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 180927s2018 gw | s |||| 0|eng d | ||
| 020 | |a 9783319984285 | ||
| 024 | 7 | |a 10.1007/978-3-319-98428-5 |2 doi | |
| 035 | |a CVTIDW10746 | ||
| 040 | |a Springer-Nature |b eng |c CVTISR |e AACR2 | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nagel, Karen M. |4 aut | |
| 245 | 1 | 0 | |a Introduction to Biologic and Biosimilar Product Development and Analysis |h [electronic resource] / |c by Karen M. Nagel. |
| 250 | |a 1st ed. 2018. | ||
| 260 | 1 | |a Cham : |b Springer International Publishing, |c 2018. | |
| 300 | |a XI, 109 p. 4 illus. in color. |b online resource. | ||
| 490 | 1 | |a AAPS Introductions in the Pharmaceutical Sciences, |x 2522-834X | |
| 500 | |a Biomedical and Life Sciences | ||
| 505 | 0 | |a Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars. | |
| 516 | |a text file PDF | ||
| 520 | |a The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies. | ||
| 650 | 0 | |a Pharmaceutical technology. | |
| 650 | 0 | |a Pharmacy. | |
| 856 | 4 | 0 | |u http://hanproxy.cvtisr.sk/han/cvti-ebook-springer-eisbn-978-3-319-98428-5 |y Vzdialený prístup pre registrovaných používateľov |
| 910 | |b ZE08026 | ||
| 919 | |a 978-3-319-98428-5 | ||
| 974 | |a andrea.lebedova |f Elektronické zdroje | ||
| 992 | |a SUD | ||
| 999 | |c 236224 |d 236224 | ||